Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$565,821,554
+$136,439,807 QoQ
Shares Held
471,742
+1.1% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#130
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STOREBRAND ASSET MANAGEMENT AS holds $1,607,022,504 across 10 Drug Manufacturers - General names. LLY ranks #1 (35.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
471,742 | $565,821,554 | |
| 2 | ABBV |
AbbVie Inc.
|
1,078,470 | $271,386,190 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,685,911 | $216,639,563 | |
| 4 | PFE |
Pfizer Inc
|
5,190,196 | $124,979,919 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
939,277 | $118,668,256 | |
| 6 | AMGN |
Amgen Inc
|
325,992 | $118,048,223 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,753,508 | $101,037,130 | |
| 8 | JNJ |
Johnson & Johnson
|
342,270 | $86,926,311 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $565,821,554 | 471,742 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $429,381,747 | 466,836 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $497,899,290 | 463,300 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $345,640,526 | 453,002 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $343,110,909 | 440,151 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $358,798,429 | 434,428 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $351,656,808 | 455,514 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $408,152,558 | 460,700 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $412,575,328 | 455,693 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $352,861,651 | 453,573 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $282,667,817 | 484,917 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $252,646,615 | 470,364 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $215,004,349 | 458,451 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $160,377,826 | 467,002 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $167,174,978 | 456,962 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $141,475,002 | 437,529 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $137,869,404 | 425,221 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $119,298,019 | 416,587 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $117,334,665 | 424,787 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $91,968,066 | 398,044 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $96,707,792 | 421,348 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $78,920,614 | 422,442 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $66,220,398 | 392,208 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $65,116,366 | 439,916 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $66,816,334 | 406,970 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $49,175,130 | 354,492 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||